INTRAVENOUS IRON TREATMENT IN PREGNANCY: COMPARISON OF HIGH DOSE CARBOXYMALTOSE VS IRON SUCROSE

INTRAVENOUS IRON TREATMENT IN PREGNANCY: COMPARISON OF HIGH DOSE CARBOXYMALTOSE VS IRON SUCROSE

Objective: To determine the efficacy of high dose carboxymaltose vs iron sucrose for anemia among pregnant women managed at our hospital. Study Design: Comparative cross-sectional study. Place and Duration of Study: Gynecology and Obstetrics department, Pak Emirates Military Hospital Rawalpind...

Full description

Bibliographic Details
Main Authors:	Faiqa Chugtai, Humna Syed, Mehwish Ara Shams, Amim Muhammad Akhter, Ali Arslan Munir, Sumbal Rana
Format:	Article
Language:	English
Published:	Army Medical College Rawalpindi 2020-10-01
Series:	Pakistan Armed Forces Medical Journal
Subjects:	anemia iron preparations parenteral
Online Access:	https://www.pafmj.org/index.php/PAFMJ/article/view/5587/2988

Similar Items

The Efficacy of Intravenous Non-dextran Iron Sucrose in the Treatment of Iron-Deficiency Anemia in Pregnancy
by: Azra Arıcı Özkan, et al.
Published: (2006-08-01)

Comparison of the use of intravenous iron sucrose with intravenous ferric Carboxymaltose for treatment of iron deficiency anaemia in pregnant patients
by: Khar un-Nisa, et al.
Published: (2022-11-01)

Intravenous ferric carboxymaltose for the treatment of iron deﬁciency anemia
by: João Ricardo Friedrisch, et al.
Published: (2015-12-01)

IV Ferric Carboxymaltose Vs Oral Iron in the Treatment of Post-partum Iron Deficiency Anaemia
by: Sree Chandana Damineni, et al.
Published: (2016-11-01)

Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials
by: Amreen Naqash, et al.
Published: (2018-01-01)

Effectiveness of intravenous ferric carboxymaltose in improving hemoglobin level among postpartum women with moderate-to-severe anemia at a secondary care hospital in Faridabad, Haryana – An interventional study
by: Shashi Kant, et al.
Published: (2020-01-01)

A comparative study of ferric carboxymaltose and iron sucrose as a parenteral iron treatment in iron deficiency anemia during pregnancy in a tertiary care hospital
by: Sandip Kumar Ghosh, et al.
Published: (2024-04-01)

Effectiveness and Safety of Intravenous Iron Sucrose Therapy in Children with Iron Deficiency Anemia
by: Muhammad Sohail Khan, et al.
Published: (2022-06-01)

Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia.
by: Ahmad Basha, et al.
Published: (2021-01-01)

Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia
by: Ahmad Basha, et al.
Published: (2021-01-01)

Evaluation of Minimal Optimal Dose of Intravenous Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia and Risk of Transient Hyperferritinemia
by: Alharbi AA, et al.
Published: (2022-11-01)

Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
by: Rodolfo Delfini Cançado, et al.
Published: (2011-12-01)

To evaluate the efficacy and safety of intravenous ferrous carboxymaltose compared with Iron sucrose in treating iron deficiency anemia in postpartum period
by: Akriti Gupta, et al.
Published: (2022-12-01)

Comparing the efficacy between ferrous carboxymaltose and iron sucrose therapy in iron deficiency anemia during pregnancy in Obstetrics and Gynecology ward at tertiary care hospital, Jaipur
by: Kamal Saini, et al.
Published: (2020-01-01)

Intravenous iron sucrose vs. blood transfusion in the management of moderate postpartum iron deficiency anemia: A non-randomized quasi-experimental study
by: Rehana Arjuman Hye, et al.
Published: (2022-02-01)

Cost-minimization analysis in iron-deficiency anemia comparing intravenous ferric carboxymaltose to standard of care in pregnant women in Algeria
by: Lama Aladham, et al.
Published: (2023-01-01)

Comparison of efficacy and safety of intravenous iron sucrose and intramuscular iron sorbitol therapy in patients with anemia during pregnancy in a developing country
by: Harsha Shailesh Gaikwad
Published: (2017-08-01)

Efficacy and safety of intravenous ferric carboxymaltose in iron deficiency anemia; Real-life data from Turkey, a single center experience
by: Ali Eser, et al.
Published: (2021-06-01)

Iron Sucrose Versus Oral Iron Therapy in Pregnancy Anemia
by: Syal Neeru, et al.
Published: (2012-01-01)

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
by: Jesse M. G. Hofman, et al.
Published: (2018-09-01)

Use of oral iron in managing iron deficiency anemia in children with intestinal failure
by: Badr Alsaleem, et al.
Published: (2021-12-01)

Intravenous Iron sucrose induced bullous pemphigoid: A rare case report
by: Kaustav Saha, et al.
Published: (2021-01-01)

Iron deficiency anemia with menorrhagia: Ferric carboxymaltose a safer alternative to blood transfusion
by: Vineet Mishra, et al.
Published: (2018-01-01)

IN WHAT CASES DOES A PEDIATRICIAN MUST PRESCRIBE IRON PREPARATIONS PARENTERALLY?
by: I. N. Zakharova, et al.
Published: (2016-12-01)

Evaluation of iron stores in hemodialysis patients on maintenance ferric Carboxymaltose dosing
by: Matthias Diebold, et al.
Published: (2019-03-01)

Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.
by: Xavier Calvet, et al.
Published: (2012-01-01)

Intravenous Iron Carboxymaltose as a Potential Therapeutic in Anemia of Inflammation.
by: Niklas Lofruthe, et al.
Published: (2016-01-01)

Intravenous ferric carboxymaltose for the treatment of iron deficiency anaemia – reply
by: Rodolfo Delfini Cancado, et al.
Published: (2020-01-01)

Ferric carboxymaltose for treatment of iron deficiency and iron deficiency anemia caused by abnormal uterine bleeding
by: Ahmed Hagras, et al.
Published: (2022-12-01)

EFFECTIVNESS OF IRON CARBOXYMALTOSATE IN PATIENTS WITH HYPOFERRIC ANEMIA ON THE BACKGROUND OF UTERINE HEMORRHAGES. CLINICAL OBSERVATION
by: N. A. Buralkina, et al.
Published: (2016-12-01)

Clinical and economic benefits of parenteral iron carboxymaltosate in patients with gynecological cancers: A retrospective observational study
by: Valeriya V. Saevets, et al.
Published: (2023-12-01)

ADMINISTRATION OF IRON(III)-HYDROXIDE POLYMALTOSE IN THE TREATMENT OF IRON DEFICIENCY ANEMIA IN CHILDREN
by: L. V. Lovtsova
Published: (2017-12-01)

Delayed Hypersensitivity with Ferric Carboxymaltose
by: Surabhi Sridhara, et al.
Published: (2017-11-01)

Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
by: Sakiyeva Kanshaiym, et al.
Published: (2020-01-01)

Iron Deficiency Anemia in Inflammatory Bowel Disease: What Do We Know?
by: Tamás Resál, et al.
Published: (2021-07-01)

A comparative study to evaluate oral iron and intravenous iron sucrose for treatment of anemia in pregnancy in a poor socioeconomic region of Northeast India
by: Maureen P Tigga, et al.
Published: (2020-01-01)

Ferric carboxymaltose solution versus iron sucrose complex in treating Iron-deficiency anemia patients with heavy uterine bleeding: A cost-efficacy study from a tertiary care hospital in the Kingdom of Saudi Arabia
by: Ayman Hejazi, et al.
Published: (2021-01-01)

Therapy of iron-deficiency anemia in gynecological patients
by: V. E. Zhorova
Published: (2019-04-01)

Iron deficiency anemia in pregnant and postpartum women - choosing drugs for treatment
by: N. V. Dubrovina, et al.
Published: (2016-12-01)

Features of labor and postpartum period in women with iron deficiency anemia
by: A. S. Atajanyan, et al.
Published: (2019-11-01)